Work

Proportion of Patients with FLT3 Positive AML Required to Enroll on Clinical Trials to Satisfy the Recruitment Needs of FLT3 Inhibitor Trials: Are We Running out of Patients?

Year: 2018

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2018-99-120142

Authors: Taylor Bucy, John Zoscak, Motomi Mori, Vinayak Prasad, Uma Borate

Institutions: Oregon Health & Science University, OHSU Knight Cancer Institute, National Institutes of Health

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2908150266

Cites:

Cited by:

Related to: 10